IBDEI0D0 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5964,1,3,0)
 ;;=3^Photocontact Dermatitis
 ;;^UTILITY(U,$J,358.3,5964,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,5964,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,5965,0)
 ;;=L56.3^^30^385^268
 ;;^UTILITY(U,$J,358.3,5965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5965,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,5965,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,5965,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,5966,0)
 ;;=L57.0^^30^385^12
 ;;^UTILITY(U,$J,358.3,5966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5966,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,5966,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,5966,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,5967,0)
 ;;=L60.0^^30^385^161
 ;;^UTILITY(U,$J,358.3,5967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5967,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,5967,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,5967,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,5968,0)
 ;;=L60.1^^30^385^234
 ;;^UTILITY(U,$J,358.3,5968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5968,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,5968,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,5968,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,5969,0)
 ;;=L60.2^^30^385^233
 ;;^UTILITY(U,$J,358.3,5969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5969,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,5969,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,5969,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,5970,0)
 ;;=L60.3^^30^385^170
 ;;^UTILITY(U,$J,358.3,5970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5970,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,5970,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,5970,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,5971,0)
 ;;=L60.4^^30^385^88
 ;;^UTILITY(U,$J,358.3,5971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5971,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,5971,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,5971,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,5972,0)
 ;;=L60.5^^30^385^290
 ;;^UTILITY(U,$J,358.3,5972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5972,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,5972,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,5972,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,5973,0)
 ;;=L60.8^^30^385^168
 ;;^UTILITY(U,$J,358.3,5973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5973,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,5973,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,5973,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,5974,0)
 ;;=L62.^^30^385^169
 ;;^UTILITY(U,$J,358.3,5974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5974,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,5974,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,5974,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,5975,0)
 ;;=L64.9^^30^385^33
 ;;^UTILITY(U,$J,358.3,5975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5975,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,5975,1,4,0)
 ;;=4^L64.9
 ;;^UTILITY(U,$J,358.3,5975,2)
 ;;=^5009249
 ;;^UTILITY(U,$J,358.3,5976,0)
 ;;=L65.9^^30^385^231
 ;;^UTILITY(U,$J,358.3,5976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5976,1,3,0)
 ;;=3^Nonscarring Hair Loss,Unspec
 ;;^UTILITY(U,$J,358.3,5976,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,5976,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,5977,0)
 ;;=L70.0^^30^385^6
 ;;^UTILITY(U,$J,358.3,5977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5977,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,5977,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,5977,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,5978,0)
 ;;=L70.1^^30^385^1
 ;;^UTILITY(U,$J,358.3,5978,1,0)
 ;;=^358.31IA^4^2
